Helius Medical Technologies Inc [NASDAQ: HSDT] price plunged by -0.31 percent to reach at $5769999.67.
A sum of 8858954 shares traded at recent session while its average daily volume was at 5.77M shares. Helius Medical Technologies Inc shares reached a high of $0.3792 and dropped to a low of $0.3121 until finishing in the latest session at $5770000.0.
The one-year HSDT stock forecast points to a potential downside of -9616566.67. The average equity rating for HSDT stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Helius Medical Technologies Inc [HSDT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HSDT shares is $60.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HSDT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Noble Capital Markets have made an estimate for Helius Medical Technologies Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 24, 2021.
The Price to Book ratio for the last quarter was 0.10, with the Price to Cash per share for the same quarter was set at 2.12.
HSDT Stock Performance Analysis:
Helius Medical Technologies Inc [HSDT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.97. With this latest performance, HSDT shares dropped by -92.22% in over the last four-week period, additionally sinking by -95.49% over the last 6 months – not to mention a drop of -96.77% in the past year of trading.
Insight into Helius Medical Technologies Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Helius Medical Technologies Inc [HSDT] shares currently have an operating margin of -3331.34% and a Gross Margin at -39.40%. Helius Medical Technologies Inc’s Net Margin is presently recorded at -3010.14%.
Return on Equity for this stock declined to -282.74%, with Return on Assets sitting at -282.74%.
Helius Medical Technologies Inc [HSDT] Institutonal Ownership Details
There are presently around $6.31%, or 7.67% of HSDT stock, in the hands of institutional investors.
